157 related articles for article (PubMed ID: 2955697)
1. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. II. Sandhoff disease gene frequencies in American Jewish and non-Jewish populations.
Cantor RM; Roy C; Lim JS; Kaback MM
Am J Hum Genet; 1987 Jul; 41(1):16-26. PubMed ID: 2955697
[TBL] [Abstract][Full Text] [Related]
2. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.
Cantor RM; Lim JS; Roy C; Kaback MM
Am J Hum Genet; 1985 Sep; 37(5):912-21. PubMed ID: 4050790
[TBL] [Abstract][Full Text] [Related]
3. Segregation of Tay-Sachs and Sandhoff alleles in a non-Jewish family.
Lane AB; Young E; Jenkins T
Am J Hum Genet; 1980 Nov; 32(6):920-6. PubMed ID: 7446530
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.
Branda KJ; Tomczak J; Natowicz MR
Genet Test; 2004; 8(2):174-80. PubMed ID: 15345116
[TBL] [Abstract][Full Text] [Related]
5. A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers: implications for carrier screening.
Triggs-Raine BL; Mules EH; Kaback MM; Lim-Steele JS; Dowling CE; Akerman BR; Natowicz MR; Grebner EE; Navon R; Welch JP
Am J Hum Genet; 1992 Oct; 51(4):793-801. PubMed ID: 1384323
[TBL] [Abstract][Full Text] [Related]
6. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
7. The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin.
Petersen GM; Rotter JI; Cantor RM; Field LL; Greenwald S; Lim JS; Roy C; Schoenfeld V; Lowden JA; Kaback MM
Am J Hum Genet; 1983 Nov; 35(6):1258-69. PubMed ID: 6650504
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity for Tay-Sachs and Sandhoff diseases among Massachusetts residents with French Canadian background.
Prence EM; Jerome CA; Triggs-Raine BL; Natowicz MR
J Med Screen; 1997; 4(3):133-6. PubMed ID: 9368869
[TBL] [Abstract][Full Text] [Related]
9. Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.
Akerman BR; Natowicz MR; Kaback MM; Loyer M; Campeau E; Gravel RA
Am J Hum Genet; 1997 May; 60(5):1099-106. PubMed ID: 9150157
[TBL] [Abstract][Full Text] [Related]
10. Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.
Paw BH; Tieu PT; Kaback MM; Lim J; Neufeld EF
Am J Hum Genet; 1990 Oct; 47(4):698-705. PubMed ID: 2220809
[TBL] [Abstract][Full Text] [Related]
11. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
12. Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.
Navon R; Proia RL
Am J Hum Genet; 1991 Feb; 48(2):412-9. PubMed ID: 1825014
[TBL] [Abstract][Full Text] [Related]
13. Incidence and carrier frequency of Sandhoff disease in Saskatchewan determined using a novel substrate with detection by tandem mass spectrometry and molecular genetic analysis.
Fitterer B; Hall P; Antonishyn N; Desikan R; Gelb M; Lehotay D
Mol Genet Metab; 2014 Mar; 111(3):382-389. PubMed ID: 24461908
[TBL] [Abstract][Full Text] [Related]
14. Tay-Sachs disease heterozygote detection in Brazil: comparison between tears and leukocytes as beta-hexosaminidase A source.
Buchalter MS; Wannmacher CM; Wajner M
J Inherit Metab Dis; 1984; 7(1):35-7. PubMed ID: 6234430
[TBL] [Abstract][Full Text] [Related]
15. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
Strasberg PM; Clarke JT
Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
[TBL] [Abstract][Full Text] [Related]
16. Sandhoff disease in Cyprus: population screening by biochemical and DNA analysis indicates a high frequency of carriers in the Maronite community.
Drousiotou A; Stylianidou G; Anastasiadou V; Christopoulos G; Mavrikiou E; Georgiou T; Kalakoutis G; Oladimeji A; Hara Y; Suzuki K; Furihata K; Ueno I; Ioannou PA; Fensom AH
Hum Genet; 2000 Jul; 107(1):12-7. PubMed ID: 10982028
[TBL] [Abstract][Full Text] [Related]
17. A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.
Cao Z; Natowicz MR; Kaback MM; Lim-Steele JS; Prence EM; Brown D; Chabot T; Triggs-Raine BL
Am J Hum Genet; 1993 Dec; 53(6):1198-205. PubMed ID: 7902672
[TBL] [Abstract][Full Text] [Related]
18. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
Natowicz MR; Prence EM
Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
[TBL] [Abstract][Full Text] [Related]
19. Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.
Drucker L; Proia RL; Navon R
Am J Hum Genet; 1992 Aug; 51(2):371-7. PubMed ID: 1322637
[TBL] [Abstract][Full Text] [Related]
20. Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.
Karpati M; Gazit E; Goldman B; Frisch A; Colombo R; Peleg L
Neurogenetics; 2004 Feb; 5(1):35-40. PubMed ID: 14648242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
